Catalyst Pharmaceuticals
CPRX
#3701
Rank
NZ$6.74 B
Marketcap
NZ$55.09
Share price
0.03%
Change (1 day)
56.17%
Change (1 year)

Catalyst Pharmaceuticals (CPRX) - Cash on Hand

Cash on Hand as of March 2026 : NZ$1.32 Billion

According to Catalyst Pharmaceuticals's latest financial reports the company has NZ$1.32 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Catalyst Pharmaceuticals - Cash on Hand chart (from 2004 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31NZ$1.22 B33.43%
2024-12-31NZ$0.91 B321.66%
2023-12-31NZ$0.21 B-53.69%
2022-12-31NZ$0.46 B67.84%
2021-12-31NZ$0.28 B44.03%
2020-12-31NZ$0.19 B38.53%
2019-12-31NZ$0.14 B76.02%
2018-12-31NZ$79.73 M-32.6%
2017-12-31NZ$0.11 B102.8%
2016-12-31NZ$58.33 M-31.63%
2015-12-31NZ$85.32 M70.21%
2014-12-31NZ$50.12 M73.73%
2013-12-31NZ$28.85 M53.96%
2012-12-31NZ$18.74 M142.6%
2011-12-31NZ$7.72 M8.85%
2010-12-31NZ$7.09 M-33.74%
2009-12-31NZ$10.71 M-47.18%
2008-12-31NZ$20.27 M-2.59%
2007-12-31NZ$20.81 M-28.24%
2006-12-31NZ$29 M2470.99%
2005-12-31NZ$1.12 M337.73%
2004-12-31NZ$0.25 M
2002-12-31NZ$0.2 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
NZ$38.62 B 2,817.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$22.90 B 1,629.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$12.77 B 865.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
NZ$1.14 B-13.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
NZ$16.4 M-98.76%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$3.89 B 194.03%๐Ÿ‡บ๐Ÿ‡ธ USA